Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

John Maris

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Anatomy

Living Beings

Infant
Mice

Procedures

Chemicals & Drugs

Genes & Molecular Sequences

Physiology

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Carol Hernan; Lock Richard; Houghton Peter J; Morton Christopher L; Kolb E Anders; Gorlick Richard; Reynolds C Patrick; Maris John M; Keir Stephen T; Billups Catherine A; Smith Malcolm A
Initial testing (stage 1) of the kinesin spindle protein inhibitor ispinesib by the pediatric preclinical testing program.
Gorlick Richard; Kolb E Anders; Houghton Peter J; Morton Christopher L; Phelps Doris; Schaiquevich Paula; Stewart Clinton; Keir Stephen T; Lock Richard; Carol Hernan; Reynolds C Patrick; Maris John M; Wu Jianrong; Smith Malcolm A
Initial testing (stage 1) of lapatinib by the pediatric preclinical testing program.
Mossé Yael P; Wood Andrew; Maris John M
Inhibition of ALK signaling for cancer therapy.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of John Maris (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Carol Hernan; Lock Richard; Houghton Peter J; Morton Christopher L; Kolb E Anders; Gorlick Richard; Reynolds C Patrick; Maris John M; Keir Stephen T; Billups Catherine A; Smith Malcolm A
Initial testing (stage 1) of the kinesin spindle protein inhibitor ispinesib by the pediatric preclinical testing program.
Pediatric blood & cancer 2009;53(7):1255-63.
2009: Gorlick Richard; Kolb E Anders; Houghton Peter J; Morton Christopher L; Phelps Doris; Schaiquevich Paula; Stewart Clinton; Keir Stephen T; Lock Richard; Carol Hernan; Reynolds C Patrick; Maris John M; Wu Jianrong; Smith Malcolm A
Initial testing (stage 1) of lapatinib by the pediatric preclinical testing program.
Pediatric blood & cancer 2009;53(4):594-8.
2009: Mossé Yael P; Wood Andrew; Maris John M
Inhibition of ALK signaling for cancer therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(18):5609-14.
2009: Morton Christopher L; Houghton Peter J; Gorlick Richard; Kolb E Anders; Lock Richard; Carol Hernan; Keir Stephen T; Reynolds C Patrick; Kang Min H; Maris John M; Billups Catherine; Smith Malcolm A
Initial testing of aplidin by the pediatric pre-clinical testing program.
Pediatric blood & cancer 2009;53(3):509-12.
2009: Diskin Sharon J; Hou Cuiping; Glessner Joseph T; Attiyeh Edward F; Laudenslager Marci; Bosse Kristopher; Cole Kristina; Mossé Yaël P; Wood Andrew; Lynch Jill E; Pecor Katlyn; Diamond Maura; Winter Cynthia; Wang Kai; Kim Cecilia; Geiger Elizabeth A; McGrady Patrick W; Blakemore Alexandra I F; London Wendy B; Shaikh Tamim H; Bradfield Jonathan; Grant Struan F A; Li Hongzhe; Devoto Marcella; Rappaport Eric R; Hakonarson Hakon; Maris John M
Copy number variation at 1q21.1 associated with neuroblastoma.
Nature 2009;459(7249):987-91.
2009: Volchenboum Samuel L; Li Cheng; Li Shuli; Attiyeh Edward F; Reynolds C Patrick; Maris John M; Look A Thomas; George Rani E
Comparison of primary neuroblastoma tumors and derivative early-passage cell lines using genome-wide single nucleotide polymorphism array analysis.
Cancer research 2009;69(10):4143-9.
2009: Matthay Katherine K; Quach Alekist; Huberty John; Franc Benjamin L; Hawkins Randall A; Jackson Hollie; Groshen Susan; Shusterman Suzanne; Yanik Gregory; Veatch Janet; Brophy Patricia; Villablanca Judith G; Maris John M
Iodine-131--metaiodobenzylguanidine double infusion with autologous stem-cell rescue for neuroblastoma: a new approaches to neuroblastoma therapy phase I study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(7):1020-5.
2009: Attiyeh Edward F; Diskin Sharon J; Attiyeh Marc A; Mossé Yaël P; Hou Cuiping; Jackson Eric M; Kim Cecilia; Glessner Joseph; Hakonarson Hakon; Biegel Jaclyn A; Maris John M
Genomic copy number determination in cancer cells from single nucleotide polymorphism microarrays based on quantitative genotyping corrected for aneuploidy.
Genome research 2009;19(2):276-83.
2009: Maris John M
Unholy matrimony: Aurora A and N-Myc as malignant partners in neuroblastoma.
Cancer cell 2009;15(1):5-6.
2009: Park Julie R; Villablanca Judith G; London Wendy B; Gerbing Robert B; Haas-Kogan Daphne; Adkins E Stanton; Attiyeh Edward F; Maris John M; Seeger Robert C; Reynolds C Patrick; Matthay Katherine K;
Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children's Oncology Group.
Pediatric blood & cancer 2009;52(1):44-50.
2008: Diskin Sharon J; Li Mingyao; Hou Cuiping; Yang Shuzhang; Glessner Joseph; Hakonarson Hakon; Bucan Maja; Maris John M; Wang Kai
Adjustment of genomic waves in signal intensities from whole-genome SNP genotyping platforms.
Nucleic acids research 2008;36(19):e126.
2008: Mossé Yaël P; Laudenslager Marci; Longo Luca; Cole Kristina A; Wood Andrew; Attiyeh Edward F; Laquaglia Michael J; Sennett Rachel; Lynch Jill E; Perri Patrizia; Laureys Geneviève; Speleman Frank; Kim Cecilia; Hou Cuiping; Hakonarson Hakon; Torkamani Ali; Schork Nicholas J; Brodeur Garrett M; Tonini Gian P; Rappaport Eric; Devoto Marcella; Maris John M
Identification of ALK as a major familial neuroblastoma predisposition gene.
Nature 2008;455(7215):930-5.
2008: Huang Jingtao; Marcus Carole L; Bandla Preetam; Schwartz Michael S; Pepe Michelle E; Samuel John M; Panitch Howard B; Bradford Ruth M; Mosse Yael P; Maris John M; Colrain Ian M
Cortical processing of respiratory occlusion stimuli in children with central hypoventilation syndrome.
American journal of respiratory and critical care medicine 2008;178(7):757-64.
2008: Neale Geoffrey; Su Xiaoping; Morton Christopher L; Phelps Doris; Gorlick Richard; Lock Richard B; Reynolds C Patrick; Maris John M; Friedman Henry S; Dome Jeffrey; Khoury Joseph; Triche Timothy J; Seeger Robert C; Gilbertson Richard; Khan Javed; Smith Malcolm A; Houghton Peter J
Molecular characterization of the pediatric preclinical testing panel.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(14):4572-83.
2008: Fujita Tomoyuki; Igarashi Jun; Okawa Erin R; Gotoh Takahiro; Manne Jayanthi; Kolla Venkatadri; Kim Jessica; Zhao Huaqing; Pawel Bruce R; London Wendy B; Maris John M; White Peter S; Brodeur Garrett M
CHD5, a tumor suppressor gene deleted from 1p36.31 in neuroblastomas.
Journal of the National Cancer Institute 2008;100(13):940-9.
2008: Maris John M; Courtright Joshua; Houghton Peter J; Morton Christopher L; Kolb E Anders; Lock Richard; Tajbakhsh Mayamin; Reynolds C Patrick; Keir Stephen T; Wu Jianrong; Smith Malcolm A
Initial testing (stage 1) of sunitinib by the pediatric preclinical testing program.
Pediatric blood & cancer 2008;51(1):42-8.
2008: Smith Malcolm A; Morton Christopher L; Phelps Doris A; Kolb E Anders; Lock Richard; Carol Hernan; Reynolds C Patrick; Maris John M; Keir Stephen T; Wu Jianrong; Houghton Peter J
Stage 1 testing and pharmacodynamic evaluation of the HSP90 inhibitor alvespimycin (17-DMAG, KOS-1022) by the pediatric preclinical testing program.
Pediatric blood & cancer 2008;51(1):34-41.
2008: Winter Cynthia; Pawel Bruce; Seiser Eric; Zhao Huaqing; Raabe Eric; Wang Qun; Judkins Alex R; Attiyeh Edward; Maris John M
Neural cell adhesion molecule (NCAM) isoform expression is associated with neuroblastoma differentiation status.
Pediatric blood & cancer 2008;51(1):10-6.
2008: Maris John M; Mosse Yael P; Bradfield Jonathan P; Hou Cuiping; Monni Stefano; Scott Richard H; Asgharzadeh Shahab; Attiyeh Edward F; Diskin Sharon J; Laudenslager Marci; Winter Cynthia; Cole Kristina A; Glessner Joseph T; Kim Cecilia; Frackelton Edward C; Casalunovo Tracy; Eckert Andrew W; Capasso Mario; Rappaport Eric F; McConville Carmel; London Wendy B; Seeger Robert C; Rahman Nazneen; Devoto Marcella; Grant Struan F A; Li Hongzhe; Hakonarson Hakon
Chromosome 6p22 locus associated with clinically aggressive neuroblastoma.
The New England journal of medicine 2008;358(24):2585-93.
2008: Kolb E Anders; Gorlick Richard; Houghton Peter J; Morton Christopher L; Lock Richard; Carol Hernan; Reynolds C Patrick; Maris John M; Keir Stephen T; Billups Catherine A; Smith Malcolm A
Initial testing (stage 1) of a monoclonal antibody (SCH 717454) against the IGF-1 receptor by the pediatric preclinical testing program.
Pediatric blood & cancer 2008;50(6):1190-7.
2008: Lock Richard; Carol Hernan; Houghton Peter J; Morton Christopher L; Kolb E Anders; Gorlick Richard; Reynolds C Patrick; Maris John M; Keir Stephen T; Wu Jianrong; Smith Malcolm A
Initial testing (stage 1) of the BH3 mimetic ABT-263 by the pediatric preclinical testing program.
Pediatric blood & cancer 2008;50(6):1181-9.
2008: Kolb E Anders; Gorlick Richard; Houghton Peter J; Morton Christopher L; Lock Richard B; Tajbakhsh Mayamin; Reynolds C Patrick; Maris John M; Keir Stephen T; Billups Catherine A; Smith Malcolm A
Initial testing of dasatinib by the pediatric preclinical testing program.
Pediatric blood & cancer 2008;50(6):1198-206.
2008: Cole Kristina A; Attiyeh Edward F; Mosse Yael P; Laquaglia Michael J; Diskin Sharon J; Brodeur Garrett M; Maris John M
A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene.
Molecular cancer research : MCR 2008;6(5):735-42.
2008: Tajbakhsh Mimi; Houghton Peter J; Morton Christopher L; Kolb E Anders; Gorlick Richard; Maris John M; Keir Stephen T; Wu Jianrong; Reynolds C Patrick; Smith Malcolm A; Lock Richard B
Initial testing of cisplatin by the pediatric preclinical testing program.
Pediatric blood & cancer 2008;50(5):992-1000.
2008: Schlisio Susanne; Kenchappa Rajappa S; Vredeveld Liesbeth C W; George Rani E; Stewart Rodney; Greulich Heidi; Shahriari Kristina; Nguyen Nguyen V; Pigny Pascal; Dahia Patricia L; Pomeroy Scott L; Maris John M; Look A Thomas; Meyerson Matthew; Peeper Daniel S; Carter Bruce D; Kaelin William G
The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor.
Genes & development 2008;22(7):884-93.
2008: Houghton Peter J; Morton Christopher L; Kolb E Anders; Gorlick Richard; Lock Richard; Carol Hernan; Reynolds C Patrick; Maris John M; Keir Stephen T; Billups Catherine A; Smith Malcolm A
Initial testing (stage 1) of the mTOR inhibitor rapamycin by the pediatric preclinical testing program.
Pediatric blood & cancer 2008;50(4):799-805.
2008: Maris John M; Courtright Joshua; Houghton Peter J; Morton Christopher L; Gorlick Richard; Kolb E Anders; Lock Richard; Tajbakhsh Mayamin; Reynolds C Patrick; Keir Stephen T; Wu Jianrong; Smith Malcolm A
Initial testing of the VEGFR inhibitor AZD2171 by the pediatric preclinical testing program.
Pediatric blood & cancer 2008;50(3):581-7.
2008: Liu X; Mazanek P; Dam V; Wang Q; Zhao H; Guo R; Jagannathan J; Cnaan A; Maris J M; Hogarty M D
Deregulated Wnt/beta-catenin program in high-risk neuroblastomas without MYCN amplification.
Oncogene 2008;27(10):1478-88.
2008: Raabe E H; Laudenslager M; Winter C; Wasserman N; Cole K; LaQuaglia M; Maris D J; Mosse Y P; Maris J M
Prevalence and functional consequence of PHOX2B mutations in neuroblastoma.
Oncogene 2008;27(4):469-76.
2007: Mosse Yael P; Diskin Sharon J; Wasserman Nora; Rinaldi Katherine; Attiyeh Edward F; Cole Kristina; Jagannathan Jayanti; Bhambhani Karishma; Winter Cynthia; Maris John M
Neuroblastomas have distinct genomic DNA profiles that predict clinical phenotype and regional gene expression.
Genes, chromosomes & cancer 2007;46(10):936-49.
2007: Maris John M; Hogarty Michael D; Bagatell Rochelle; Cohn Susan L
Neuroblastoma.
Lancet 2007;369(9579):2106-20.
2007: Peddinti Radhika; Zeine Rana; Luca Dragos; Seshadri Roopa; Chlenski Alexandre; Cole Kristina; Pawel Bruce; Salwen Helen R; Maris John M; Cohn Susan L
Prominent microvascular proliferation in clinically aggressive neuroblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(12):3499-506.
2007: Matthay Katherine K; Yanik Gregory; Messina Julia; Quach Alekist; Huberty John; Cheng Su-Chun; Veatch Janet; Goldsby Robert; Brophy Patricia; Kersun Leslie S; Hawkins Randall A; Maris John M
Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(9):1054-60.
2007: George Rani E; Attiyeh Edward F; Li Shuli; Moreau Lisa A; Neuberg Donna; Li Cheng; Fox Edward A; Meyerson Matthew; Diller Lisa; Fortina Paolo; Look A Thomas; Maris John M
Genome-wide analysis of neuroblastomas using high-density single nucleotide polymorphism arrays.
PloS one 2007;2(2):e255.
2006: Fang Jun; Quinones Quintin J; Holman Trevor L; Morowitz Michael J; Wang Qun; Zhao Huaqing; Sivo Frank; Maris John M; Wahl Miriam L
The H+-linked monocarboxylate transporter (MCT1/SLC16A1): a potential therapeutic target for high-risk neuroblastoma.
Molecular pharmacology 2006;70(6):2108-15.
2006: Messina Julia A; Cheng Su-Chun; Franc Benjamin L; Charron Martin; Shulkin Barry; To Bao; Maris John M; Yanik Gregory; Hawkins Randall A; Matthay Katherine K
Evaluation of semi-quantitative scoring system for metaiodobenzylguanidine (mIBG) scans in patients with relapsed neuroblastoma.
Pediatric blood & cancer 2006;47(7):865-74.
2006: Moreau Lisa A; McGrady Patrick; London Wendy B; Shimada Hiroyuki; Cohn Susan L; Maris John M; Diller Lisa; Look A Thomas; George Rani E
Does MYCN amplification manifested as homogeneously staining regions at diagnosis predict a worse outcome in children with neuroblastoma? A Children's Oncology Group study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(19):5693-7.
2006: Mahoney Nicholas R; Liu Grant T; Menacker Sheryl J; Wilson Martin C; Hogarty Michael D; Maris John M
Pediatric horner syndrome: etiologies and roles of imaging and urine studies to detect neuroblastoma and other responsible mass lesions.
American journal of ophthalmology 2006;142(4):651-9.
2006: Diskin Sharon J; Eck Thomas; Greshock Joel; Mosse Yael P; Naylor Tara; Stoeckert Christian J; Weber Barbara L; Maris John M; Grant Gregory R
STAC: A method for testing the significance of DNA copy number aberrations across multiple array-CGH experiments.
Genome research 2006;16(9):1149-58.
2006: Teachey David T; Obzut Dana A; Axsom Kelly; Choi John K; Goldsmith Kelly C; Hall Junior; Hulitt Jessica; Manno Catherine S; Maris John M; Rhodin Nicholas; Sullivan Kathleen E; Brown Valerie I; Grupp Stephan A
Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS).
Blood 2006;108(6):1965-71.
2006: Wang Qun; Diskin Sharon; Rappaport Eric; Attiyeh Edward; Mosse Yael; Shue Daniel; Seiser Eric; Jagannathan Jayanti; Shusterman Suzanne; Bansal Manisha; Khazi Deepa; Winter Cynthia; Okawa Erin; Grant Gregory; Cnaan Avital; Zhao Huaqing; Cheung Nai-Kong; Gerald William; London Wendy; Matthay Katherine K; Brodeur Garrett M; Maris John M
Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number.
Cancer research 2006;66(12):6050-62.
2006: Matthay Katherine K; Tan Jessica C; Villablanca Judith G; Yanik Gregory A; Veatch Janet; Franc Benjamin; Twomey Eilish; Horn Biljana; Reynolds C Patrick; Groshen Susan; Seeger Robert C; Maris John M
Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(3):500-6.
2006: Reddy C Damodar; Patti Ratnakar; Guttapalli Asha; Maris John M; Yanamandra Niranjan; Rachamallu Aparna; Sutton Leslie N; Phillips Peter C; Posner Gary H
Anticancer effects of the novel 1alpha, 25-dihydroxyvitamin D3 hybrid analog QW1624F2-2 in human neuroblastoma.
Journal of cellular biochemistry 2006;97(1):198-206.
2005: Attiyeh Edward F; London Wendy B; Mossé Yael P; Wang Qun; Winter Cynthia; Khazi Deepa; McGrady Patrick W; Seeger Robert C; Look A Thomas; Shimada Hiroyuki; Brodeur Garrett M; Cohn Susan L; Matthay Katherine K; Maris John M;
Chromosome 1p and 11q deletions and outcome in neuroblastoma.
The New England journal of medicine 2005;353(21):2243-53.
2005: Ho Ruth; Minturn Jane E; Hishiki Tomoro; Zhao Huaqing; Wang Qun; Cnaan Avital; Maris John; Evans Audrey E; Brodeur Garrett M
Proliferation of human neuroblastomas mediated by the epidermal growth factor receptor.
Cancer research 2005;65(21):9868-75.
2005: Mosse Yael P; Greshock Joel; Weber Barbara L; Maris John M
Measurement and relevance of neuroblastoma DNA copy number changes in the post-genome era.
Cancer letters 2005;228(1-2):83-90.
2005: Shusterman Suzanne; Maris John M
Prospects for therapeutic inhibition of neuroblastoma angiogenesis.
Cancer letters 2005;228(1-2):171-9.
2005: London W B; Castleberry R P; Matthay K K; Look A T; Seeger R C; Shimada H; Thorner P; Brodeur G; Maris J M; Reynolds C P; Cohn S L
Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(27):6459-65.
2005: George Rani E; London Wendy B; Cohn Susan L; Maris John M; Kretschmar Cynthia; Diller Lisa; Brodeur Garrett M; Castleberry Robert P; Look A Thomas
Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(27):6466-73.
2005: Maris John M; Hii George; Gelfand Craig A; Varde Shobha; White Peter S; Rappaport Eric; Surrey Saul; Fortina Paolo
Region-specific detection of neuroblastoma loss of heterozygosity at multiple loci simultaneously using a SNP-based tag-array platform.
Genome research 2005;15(8):1168-76.
2005: Margolin Adam A; Greshock Joel; Naylor Tara L; Mosse Yael; Maris John M; Bignell Graham; Saeed Alexander I; Quackenbush John; Weber Barbara L
CGHAnalyzer: a stand-alone software package for cancer genome analysis using array-based DNA copy number data.
Bioinformatics (Oxford, England) 2005;21(15):3308-11.
2005: Mosse Yael P; Greshock Joel; Margolin Adam; Naylor Tara; Cole Kristina; Khazi Deepa; Hii George; Winter Cynthia; Shahzad Syed; Asziz Muhammad Usman; Biegel Jaclyn A; Weber Barbara L; Maris John M
High-resolution detection and mapping of genomic DNA alterations in neuroblastoma.
Genes, chromosomes & cancer 2005;43(4):390-403.
2005: Bellah Richard; Suzuki-Bordalo Lisa; Brecher Eric; Ginsberg Jill P; Maris John; Pawel Bruce R
Desmoplastic small round cell tumor in the abdomen and pelvis: report of CT findings in 11 affected children and young adults.
AJR. American journal of roentgenology 2005;184(6):1910-4.
2005: White Peter S; Thompson Patricia M; Gotoh Takahiro; Okawa Erin R; Igarashi Jun; Kok Marleen; Winter Cynthia; Gregory Simon G; Hogarty Michael D; Maris John M; Brodeur Garrett M
Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma.
Oncogene 2005;24(16):2684-94.
2005: Morowitz Michael J; Barr Rosalind; Wang Qun; King Rebecca; Rhodin Nicholas; Pawel Bruce; Zhao Huaqing; Erickson Scott A; Sheppard George S; Wang Jieyi; Maris John M; Shusterman Suzanne
Methionine aminopeptidase 2 inhibition is an effective treatment strategy for neuroblastoma in preclinical models.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(7):2680-5.
2005: Howard James P; Maris John M; Kersun Leslie S; Huberty John P; Cheng Su-Chun; Hawkins Randall A; Matthay Katherine K
Tumor response and toxicity with multiple infusions of high dose 131I-MIBG for refractory neuroblastoma.
Pediatric blood & cancer 2005;44(3):232-9.
2004: Mosse Yael P; Laudenslager Marci; Khazi Deepa; Carlisle Alex J; Winter Cynthia L; Rappaport Eric; Maris John M
Germline PHOX2B mutation in hereditary neuroblastoma.
American journal of human genetics 2004;75(4):727-30.
2004: DuBois Steven G; Messina Julia; Maris John M; Huberty John; Glidden David V; Veatch Janet; Charron Martin; Hawkins Randall; Matthay Katherine K
Hematologic toxicity of high-dose iodine-131-metaiodobenzylguanidine therapy for advanced neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(12):2452-60.
2004: Hickeson Marc P; Charron Martin; Maris John M; Brophy Patricia; Kang Tammy I; Zhuang Hongming; Khan Jehanzeb; Nevrotski Teresa
Biodistribution of post-therapeutic versus diagnostic (131)I-MIBG scans in children with neuroblastoma.
Pediatric blood & cancer 2004;42(3):268-74.
2003: Morowitz Michael; Shusterman Suzanne; Mosse Yael; Hii George; Winter Cynthia L; Khazi Deepa; Wang Qun; King Rebecca; Maris John M
Detection of single-copy chromosome 17q gain in human neuroblastomas using real-time quantitative polymerase chain reaction.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2003;16(12):1248-56.
2003: Mosse Yael; Greshock Joel; King Allison; Khazi Deepa; Weber Barbara L; Maris John M
Identification and high-resolution mapping of a constitutional 11q deletion in an infant with multifocal neuroblastoma.
The lancet oncology 2003;4(12):769-71.
2003: Wang Jieyi; Sheppard George S; Lou Pingping; Kawai Megumi; BaMaung Nwe; Erickson Scott A; Tucker-Garcia Lora; Park Chang; Bouska Jennifer; Wang Yi-Chun; Frost David; Tapang Paul; Albert Daniel H; Morgan Sherry J; Morowitz Michael; Shusterman Suzanne; Maris John M; Lesniewski Rick; Henkin Jack
Tumor suppression by a rationally designed reversible inhibitor of methionine aminopeptidase-2.
Cancer research 2003;63(22):7861-9.
2003: Kang Tammy I; Brophy Patricia; Hickeson Mark; Heyman Sydney; Evans Audrey E; Charron Martin; Maris John M
Targeted radiotherapy with submyeloablative doses of 131I-MIBG is effective for disease palliation in highly refractory neuroblastoma.
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 2003;25(10):769-73.
2003: Accorsi Roberto; Morowitz Michael J; Charron Martin; Maris John M
Pinhole imaging of 131I-metaiodobenzylguanidine (131I-MIBG) in an animal model of neuroblastoma.
Pediatric radiology 2003;33(10):688-92.
2003: Maris John M; Castleberry Robert P
Chemotherapy for neuroblastoma: is it all or none?
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 2003;25(7):512-4.
2003: Wang Qun; Hii George; Shusterman Suzanne; Mosse Yael; Winter Cynthia L; Guo Chun; Zhao Huaqing; Rappaport Eric; Hogarty Michael D; Maris John M
ID2 expression is not associated with MYCN amplification or expression in human neuroblastomas.
Cancer research 2003;63(7):1631-5.
2002: Maris John M; Denny Christopher T
Focus on embryonal malignancies.
Cancer cell 2002;2(6):447-50.
2002: Maris John M; Weiss Matthew J; Mosse Yael; Hii George; Guo Chun; White Peter S; Hogarty Michael D; Mirensky Tamar; Brodeur Garrett M; Rebbeck Timothy R; Urbanek Margrit; Shusterman Suzanne
Evidence for a hereditary neuroblastoma predisposition locus at chromosome 16p12-13.
Cancer research 2002;62(22):6651-8.
2002: Hogarty Michael D; Winter Cynthia L; Liu Xueyuan; Guo Chun; White Peter S; Look A Thomas; Brodeur Garrett M; Maris John M
No evidence for the presence of an imprinted neuroblastoma suppressor gene within chromosome sub-band 1p36.3.
Cancer research 2002;62(22):6481-4.
2001: Shusterman S; Grupp S A; Barr R; Carpentieri D; Zhao H; Maris J M
The angiogenesis inhibitor tnp-470 effectively inhibits human neuroblastoma xenograft growth, especially in the setting of subclinical disease.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(4):977-84.
2001: Hogarty M D; Maris J M; White P S; Guo C; Brodeur G M
Analysis of genomic imprinting at 1p35-36 in neuroblastoma.
Medical and pediatric oncology 2001;36(1):52-5.
2001: White P S; Thompson P M; Seifried B A; Sulman E P; Jensen S J; Guo C; Maris J M; Hogarty M D; Allen C; Biegel J A; Matise T C; Gregory S G; Reynolds C P; Brodeur G M
Detailed molecular analysis of 1p36 in neuroblastoma.
Medical and pediatric oncology 2001;36(1):37-41.
2001: Maris J M; Guo C; Blake D; White P S; Hogarty M D; Thompson P M; Rajalingam V; Gerbing R; Stram D O; Matthay K K; Seeger R C; Brodeur G M
Comprehensive analysis of chromosome 1p deletions in neuroblastoma.
Medical and pediatric oncology 2001;36(1):32-6.
2001: Thompson P M; Seifried B A; Kyemba S K; Jensen S J; Guo C; Maris J M; Brodeur G M; Stram D O; Seeger R C; Gerbing R; Matthay K K; Matise T C; White P S
Loss of heterozygosity for chromosome 14q in neuroblastoma.
Medical and pediatric oncology 2001;36(1):28-31.
2001: Maris J M; Guo C; White P S; Hogarty M D; Thompson P M; Stram D O; Gerbing R; Matthay K K; Seeger R C; Brodeur G M
Allelic deletion at chromosome bands 11q14-23 is common in neuroblastoma.
Medical and pediatric oncology 2001;36(1):24-7.
2001: Brodeur G M; Look A T; Shimada H; Hamilton V M; Maris J M; Hann H W; Leclerc J M; Bernstein M; Brisson L C; Brossard J; Lemieux B; Tuchman M; Woods W G
Biological aspects of neuroblastomas identified by mass screening in Quebec.
Medical and pediatric oncology 2001;36(1):157-9.
2001: Thompson P M; Maris J M; Hogarty M D; Seeger R C; Reynolds C P; Brodeur G M; White P S
Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma.
Cancer research 2001;61(2):679-86.
2000: Shusterman S; Grupp S A; Maris J M
Inhibition of tumor growth in a human neuroblastoma xenograft model with TNP-470.
Medical and pediatric oncology 2000;35(6):673-6.
2000: Hogarty M D; Liu X; Thompson P M; White P S; Sulman E P; Maris J M; Brodeur G M
BIN1 inhibits colony formation and induces apoptosis in neuroblastoma cell lines with MYCN amplification.
Medical and pediatric oncology 2000;35(6):559-62.
2000: Guo C; White P S; Hogarty M D; Brodeur G M; Gerbing R; Stram D O; Maris J M
Deletion of 11q23 is a frequent event in the evolution of MYCN single-copy high-risk neuroblastomas.
Medical and pediatric oncology 2000;35(6):544-6.
2000: Weiss M J; Guo C; Shusterman S; Hii G; Mirensky T L; White P S; Hogarty M D; Rebbeck T R; Teare D; Urbanek M; Brodeur G M; Maris J M
Localization of a hereditary neuroblastoma predisposition gene to 16p12-p13.
Medical and pediatric oncology 2000;35(6):526-30.
2000: Hogarty M D; Liu X; Guo C; Thompson P M; Weiss M J; White P S; Sulman E P; Brodeur G M; Maris J M
Identification of a 1-megabase consensus region of deletion at 1p36.3 in primary neuroblastomas.
Medical and pediatric oncology 2000;35(6):512-5.
2000: Maris J M; Weiss M J; Guo C; Gerbing R B; Stram D O; White P S; Hogarty M D; Sulman E P; Thompson P M; Lukens J N; Matthay K K; Seeger R C; Brodeur G M
Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(9):1888-99.
1999: Guo C; White P S; Weiss M J; Hogarty M D; Thompson P M; Stram D O; Gerbing R; Matthay K K; Seeger R C; Brodeur G M; Maris J M
Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas.
Oncogene 1999;18(35):4948-57.
1999: Maris J M; Matthay K K
Molecular biology of neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(7):2264-79.
1998: Sulman E P; Dumanski J P; White P S; Zhao H; Maris J M; Mathiesen T; Bruder C; Cnaan A; Brodeur G M
Identification of a consistent region of allelic loss on 1p32 in meningiomas: correlation with increased morbidity.
Cancer research 1998;58(15):3226-30.
1998: White P S; Jensen S J; Rajalingam V; Stairs D; Sulman E P; Maris J M; Biegel J A; Wooster R; Brodeur G M
Physical mapping of the CA6, ENO1, and SLC2A5 (GLUT5) genes and reassignment of SLC2A5 to 1p36.2.
Cytogenetics and cell genetics 1998;81(1):60-4.
1997: Maris J M; Jensen J; Sulman E P; Beltinger C P; Allen C; Biegel J A; Brodeur G M; White P S
Human Krüppel-related 3 (HKR3): a candidate for the 1p36 neuroblastoma tumour suppressor gene?
European journal of cancer (Oxford, England : 1990) 1997;33(12):1991-6.
1997: White P S; Maris J M; Sulman E P; Jensen S J; Kyemba S M; Beltinger C P; Allen C; Kramer D L; Biegel J A; Brodeur G M
Molecular analysis of the region of distal 1p commonly deleted in neuroblastoma.
European journal of cancer (Oxford, England : 1990) 1997;33(12):1957-61.
1997: Maris J M; Kyemba S M; Rebbeck T R; White P S; Sulman E P; Jensen S J; Allen C; Biegel J A; Brodeur G M
Molecular genetic analysis of familial neuroblastoma.
European journal of cancer (Oxford, England : 1990) 1997;33(12):1923-8.
1997: Jensen S J; Sulman E P; Maris J M; Matise T C; Vojta P J; Barrett J C; Brodeur G M; White P S
An integrated transcript map of human chromosome 1p35-p36.
Genomics 1997;42(1):126-36.
1997: Brodeur G M; Maris J M; Yamashiro D J; Hogarty M D; White P S
Biology and genetics of human neuroblastomas.
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 1997;19(2):93-101.
1997: Maris J M; Chatten J; Meadows A T; Biegel J A; Brodeur G M
Familial neuroblastoma: a three-generation pedigree and a further association with Hirschsprung disease.
Medical and pediatric oncology 1997;28(1):1-5.
1996: Maris J M; Kyemba S M; Rebbeck T R; White P S; Sulman E P; Jensen S J; Allen C; Biegel J A; Yanofsky R A; Feldman G L; Brodeur G M
Familial predisposition to neuroblastoma does not map to chromosome band 1p36.
Cancer research 1996;56(15):3421-5.
1996: Maris J M; Jensen S J; Sulman E P; Beltinger C P; Gates K; Allen C; Biegel J A; Brodeur G M; White P S
Cloning, chromosomal localization, physical mapping, and genomic characterization of HKR3.
Genomics 1996;35(2):289-98.
1996: Beltinger C P; White P S; Maris J M; Sulman E P; Jensen S J; LePaslier D; Stallard B J; Goeddel D V; de Sauvage F J; Brodeur G M
Physical mapping and genomic structure of the human TNFR2 gene.
Genomics 1996;35(1):94-100.
1995: Maris J M; White P S; Beltinger C P; Sulman E P; Castleberry R P; Shuster J J; Look A T; Brodeur G M
Significance of chromosome 1p loss of heterozygosity in neuroblastoma.
Cancer research 1995;55(20):4664-9.
1995: White P S; Maris J M; Beltinger C; Sulman E; Marshall H N; Fujimori M; Kaufman B A; Biegel J A; Allen C; Hilliard C
A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(12):5520-4.
1995: Beltinger C P; White P S; Sulman E P; Maris J M; Brodeur G M
No CDKN2 mutations in neuroblastomas.
Cancer research 1995;55(10):2053-5.
1995: Maris J M; Butler R B; Cohen A R
Loss of detectable antibody to hepatitis B surface antigen in immunized patients with hemophilia but without human immunodeficiency virus infection.
The Journal of pediatrics 1995;126(2):269-71.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

John Maris

Research Profile (preview)

Disorders

Anatomy

Living Beings

Procedures

Chemicals & Drugs

Genes & Molecular Sequences

Physiology

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of John Maris (preview)

All Publications